Major new study: Hormone therapy benefits outweigh risks in menopause
A recent study published in JAMA suggests that the benefits of hormone therapy outweigh the risks for treating menopause symptoms, particularly among women under 60.
A recent study published in JAMA suggests that the benefits of hormone therapy outweigh the risks for treating menopause symptoms, particularly among women under 60.
This week, APC submitted a comment letter to the Massachusetts Board of Pharmacy about two issues on which the Board recently expressed concern.
This week, APC wrote to state boards of pharmacy and FDA to make them aware of delays in completing stability studies as USP 797 is enforced across the country.
Wells Pharmacy Network is our newest Bronze-level Corporate Patron — a $10,000 investment.
You know this by now: You can’t believe everything you read in the news, especially when it comes to compounding.
You may know EduCon as APC’s “Ethical Compounding Conference” – a virtual event that delivers “best practices” training to compounding pharmacists and technicians. This year, it’s back with a new user-friendly format.
With the passing of Dr. Loyd V. Allen, Jr., PhD, this week, our profession lost a giant. No hyperbole here: His passion for and influence over the ethical practice of pharmacy compounding is simply unequalled.
Be aware: FDA has issued a number of 483s related to the water used in nonsterile compounding. Water for nonsterile compounds needs to be USP-grade purified water.
We have several new PFM-only resources now available on our website. Make sure you’re logged in so you can access them.
APC’s Scott Brunner and Tenille Davis are guests on the latest GameChangers Pharmacotherapy Podcast, where they cover facts and misinformation around compounded GLP-1s.